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Abstract. The outbreak of coronavirus disease 2019 (COVID-19) is rapidly changing
our habits. To date, April 12, 2020, the virus has reached 209 nations, affecting 1.8
million people and causing more than 110,000 deaths. Maxillofacial surgery
represents an example of a specialty that has had to adapt to this outbreak, because
of the subspecialties of oncology and traumatology. The aim of this study was to
examine the effect of this outbreak on the specialty of maxillofacial surgery and
how the current situation is being managed on a worldwide scale. To achieve this
goal, the authors developed an anonymous questionnaire which was posted on the
internet and also sent to maxillofacial surgeons around the globe using membership
lists from various subspecialty associations. The questionnaire asked for
information about the COVID-19 situation in the respondent’s country and in their
workplace, and what changes they were facing in their practices in light of the
outbreak. The objective was not only to collect and analyse data, but also to
highlight what the specialty is facing and how it is handling the situation, in the hope
that this information will be useful as a reference in the future, not only for this
specialty, but also for others, should COVID-19 or a similar global threat arise
again.Please cite this article in press as: Maffia F, et al. Impact of COVID-19 on maxillofacial surge
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Accepted for publication 24 April 2020The outbreak of coronavirus disease 2019
(COVID-19), caused by severe acute re-
spiratory syndrome coronavirus 2
(COVID-19), is rapidly changing our
habits. Since December 2019, the news
of a pneumonia focus of unknown cause in
the city of Wuhan, Hubei Province, China,
has shaken the whole world1. To date,
April 12, 2020, the virus has reached
209 nations, affecting 1.8 million people
and causing more than 110,000 deaths2.
More and more governments have been
forced to take significant countermeasuresin the face of the rapid spread of this
disease. Two of the main tasks are to
reduce the likelihood of the infection
and enhance each country’s healthcare
system resources.
In affected regions, hospitals are mak-
ing decisions based on their resources as to
which departments will directly deal with
COVID-19 patients and those that will
not. The natural consequence of this will
be that the latter departments will only be
treating emergencies, so as not to expose
both the patients and staff to the risk ofinfection and to allow a better distribution
of the necessary resources to the depart-
ments actually managing COVID-19
patients.
Maxillofacial surgery represents an ex-
ample of a specialty that has had to adapt
to this outbreak, because of the subspe-
cialties of oncology and traumatology.
Considering the varied socio-political
situations in each country, the maxillofa-
cial surgery model was considered appro-
priate to evaluate the security measures
taken by the institutions. This approachry practice: a worldwide survey, Int J Oral
ons. Published by Elsevier Ltd. All rights reserved.
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this model, on a global scale, during a very
different social reality.
The aim of this study was to examine
the effect of the COVID-19 outbreak on
the specialty of maxillofacial surgery and
how the current situation is being managed
on a worldwide scale. To achieve this
goal, the authors developed an anonymous
questionnaire which was posted on the
internet and also sent to maxillofacial
surgeons around the globe using member-
ship lists from various subspecialtyPlease cite this article in press as: Maffia F, et
Maxillofac Surg (2020), https://doi.org/10.1
Table 1. Questionnaire and results.
1 Which continent are you f
Europe 
North America 
South America 
Asia 
Africa 
Oceania 
2 Which country?
3 Which city?
4 On the basis of the DORS
Green 
Yellow 
Orange 
Red 
5 Where do you work? (One
Public hospital 
University hospital 
Private clinic 
6 Institution name
7 Number of employees (all 
8 Mark the boxes with the s
Traumatology 
Orthognathic surgery 
TMJ surgery 
Head and neck tumour s
Craniofacial surgery 
Paediatric surgery 
Dental surgery 
Oral surgery 
9 Is your department still op
Yes, and it is working n
Yes, with restrictions 
No 
10 Which specialties are still 
Traumatology 
Orthognathic surgery 
TMJ surgery 
Head and neck tumour s
Craniofacial surgery 
Paediatric surgery 
Dental surgery 
Oral surgery 
11 Number of employees (all 
12 Have any of them been as
Yes 
No 
I don’t know 
13 As a percentage, how muc
>90% 
70–90% 
50–69% 
30–49% associations. The questionnaire asked for
information about the COVID-19 situa-
tion in the respondent’s country and in
their workplace, and what changes they
were facing in their practices in light of the
outbreak. The objective was not only to
collect and analyse data, but also to high-
light what the specialty is facing and how
it is handling the situation, in the hope that
this information will be useful as a refer-
ence in the future, not only for this spe-
cialty, but also for others, should COVID-
19 or a similar global threat arise again. al. Impact of COVID-19 on maxillofacial surge
016/j.ijom.2020.04.015
rom?
CON Scale, how is the situation in your country
 or more options)
hierarchy levels) normally working in the depar
pecialties performed in your department
urgery 
en?
ormally 
working?a
urgery 
hierarchy levels) working in the department dur
signed to another department with necessity?a
h do you think your department is still active?aMaterials and methods
The survey was conducted from March 20,
2020 to April 12, 2020. The questionnaire
was developed using Google Forms. This
platform was chosen because it is free,
easy to use for both the researchers and
respondents, and it provides easily extrap-
olated data for use in Excel (Microsoft,
Redmond, WA, USA). Moreover, this
platform creates charts as the respondents
complete the questionnaire, which allows
observation of the data in real time and thery practice: a worldwide survey, Int J Oral
62 39.7%
15 9.6%
16 10.3%
50 32.1%
8 5.1%
5 3.2%
156 100.0%
?
9 5.8%
20 12.8%
37 23.7%
90 57.7%
64 41.0%
83 53.2%
67 42.9%
tment before the outbreak
125 80.1%
103 66.0%
101 64.7%
87 55.8%
54 34.6%
74 47.4%
114 73.1%
141 90.4%
6 3.8%
122 78.2%
28 17.9%
104 66.7%
9 5.8%
7 4.5%
58 37.2%
6 3.8%
11 7.1%
31 19.9%
54 34.6%
ing the outbreaka
29 22.7%
79 61.7%
20 15.6%
8 6.3%
7 5.5%
18 14.1%
20 15.6%
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<30% 75 58.6%
14 What was the reason for the department closing?b
14.1 Feel free to better explain the situation
15 Did your hospital give you guidelines to face the outbreak?
Yes 128 82.1%
No 28 17.9%
15.1 If yes, could you briefly describe what these guidelines are?
15.2 You can upload a picture or a document of these new practice rules in the following box
16 Do you think that these rules are appropriate?
Yes 92 59.0%
No 23 14.7%
I don’t know 41 26.3%
17 Do you feel safe?
Yes 81 51.9%
No 75 48.1%
18 Did the hospital give you protection? (One or more options)
FFP1 masks 50 32.1%
FFP2 masks 55 35.3%
FFP3 masks 31 19.9%
Disposable suit 75 48.1%
Protection glasses 81 51.9%
None of these 27 17.3%
Other (Open-ended)
19 Did you experience outpatient clinic visits during the outbreak?
Yes 105 67.3%
No 51 32.7%
19.1 If yes, how did you manage them? (One or more options)
Physicians were protected by PPE (personal protective equipment) 84 80.0%
Patient received PPE at the access to the hospital 21 20.0%
Furniture was moved to ensure a safe distance (1 meter or more) 43 41.0%
Waiting room was reorganized to avoid gatherings 78 74.3%
Pre-visit by telephone 65 61.9%
Access to the hospital through body temperature control 52 49.5%
Questionnaire for possible risk factors (interpersonal contacts and travel) 69 65.7%
Unnecessary physical contacts were avoided (handshakes, greetings) 101 96.2%
20 Did anything change in hospitalizations?
Yes 114 73.1%
No 42 26.9%
20.1 If yes, what?
21 Did anything change in patient preparation to undergo surgery?
Yes 77 49.4%
No 51 32.7%
I don’t know 28 17.9%
21.1 If yes, what?
22 Did anything change in already hospitalized patients?
Yes 54 34.6%
No 63 40.4%
I don’t know 39 25.0%
22.1 If yes, what?
23 Did you collect human specimens for COVID-19 screening or diagnosis? (One or more options)
Yes, for all already hospitalized patients 6 3.8%
Yes, for all patients ready to undergo surgery 3 1.9%
Yes, for all patients with known comorbidities 6 3.8%
Yes, for all symptomatic patients 30 19.2%
Yes, for all patients 0 0.0%
No 115 73.7%
24 Did your department face patients who were positive for the COVID-19 virus?
Yes 21 13.5%
No 93 59.6%
I don’t know 42 26.9%
24.1 If yes, how did you manage them?
25 Have department workers been tested for COVID-19?
Yes 27 17.3%
No 107 68.5%
I don’t know 22 14.1%
DORSCON Scale, Disease Outbreak Response System Condition; FFP, filtering facepiece; PPE, personal protective equipment; SARS-CoV-2,
severe acute respiratory syndrome coronavirus 2; TMJ, temporomandibular joint.
a Question asked only if the answer was ‘Yes, and it works normally’ or ‘Yes, with restrictions’ to question number 9.
bQuestions asked only if the answer was ‘No’ to question number 9.
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as figures in publications.
The questionnaire was produced in En-
glish and included 33 questions, both mul-
tiple-choice and open-ended, and was
divided into three sections (Table 1). The
first section asked for general information
about the respondent: country, institution
name, and the situation in the country
according to the DORSCON Scale (Disease
Outbreak Response System Condition).
The DORSCON Scale is a colour-based
representation that describes the current
disease situation. The Scale is divided into
four colours indicating the gravity of the
situation: green, yellow, orange, and red. It
takes into account the nature of the disease
and its impact on daily life, and provides
general indications and advice to the pub-
lic3.
The second section was structured to
obtain a snapshot of the respondent’s
workplace and medical practice before
the outbreak: private, public, university-
based practice, the number of employees,
and the maxillofacial services offered.
The third section focused on the prac-
tice situation during the outbreak. The
respondents were asked to explain what
changes were occurring in the organiza-
tion of their hospital and what measures
had been adopted to protect staff and
patients. Any direct contact with patients
suffering from COVID-19 was queried. It
was also asked whether anyone in the
respondent’s department had been
infected with COVID-19. The respondentsPlease cite this article in press as: Maffia F, et
Maxillofac Surg (2020), https://doi.org/10.1
Fig. 1. Participating countries. The colour scalecould also upload files, such as any
COVID-19 guidelines, that they might
have received from their institution or
hospital.
The questionnaire internet link was dis-
tributed by e-mail via personal invitation,
Facebook, WhatsApp, LinkedIn, and
ResearchGate. Furthermore, the executive
secretaries of both the American Society
of Temporomandibular Joint Surgeons
(ASTMJS) and the European Society of
Temporomandibular Joint Surgeons
(ESTMJS) kindly allowed the survey to
be circulated in their newsletters. More-
over, the authors asked the respondents to
share the questionnaire link with their
colleagues and contacts in the maxillofa-
cial field. Ten replies were received in
duplicate and were merged accordingly.
To improve the analysis of the results
concerning the subspecialties still working
during the outbreak, the outbreak activity
index (OAI) was introduced. The OAI was
defined as the residual activity in the
analysed centre for each specialty and
was calculated as the ratio of specialties
active during the emergency divided by
the specialties previously active, multi-
plied by a factor of 100.
Results
A total of 166 responses to the survey were
acquired from 54 countries. The number
of replies per country varied from a mini-
mum of 1 to a maximum of 18 (Fig. 1). In al. Impact of COVID-19 on maxillofacial surge
016/j.ijom.2020.04.015
 bar shows the variation in the number of respototal, 156 maxillofacial surgery centres,
including public hospitals and private
practices, completed the questionnaire.
The response rate was 20.2%, out of
822 invitations sent. Only complete
responses were received, as most of the
questions were mandatory. Moreover, the
replies were only sent and received if the
respondent reached the end of the ques-
tionnaire.
Complete results are presented in Table
1. Cumulative DORSCON Scale percen-
tages are displayed in Fig. 2. The levels of
alert for each continent are reported in
Table 2.
In 82% of the responding centres that
had remained open, the maxillofacial sub-
specialties had been reorganized. Trauma-
tology was reported as the service that was
most maintained, resulting in an OAI of
83.2%. Only 13.5% of the responding
institutions had closed this subspecialty.
Oral surgery, practiced in 90.4% of cen-
ters, decreased activity to 34.6%, with an
overall reduction of 55.8% yielding and
OAI of 38.3%. Nevertheless, oral surgery
remained one of the three most active
subspecialties together with traumatology
(OAI = 83.2%) and head and neck tumour
surgery (OAI = 66.7%). The greatest re-
duction in activity occurred in both
orthognathic surgery (OAI = 8.7%) and
temporomandibular joint (TMJ) surgery
(OAI = 6.9%). The OAIs for the other
subspecialties were 11.1% for craniofacial
surgery, 14.9% for paediatric surgery, and
27.2% for dental surgery.ry practice: a worldwide survey, Int J Oral
nses from each country.
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Fig. 2. Percentage of each DORSCON Scale level for all countries.
Table 2. Level of alert of each continent based on the DORSCON Scale.
Continent Green Yellow Orange Red
Africa 0% 12.50% 50.00% 37.50%
Asia 12.00% 24.00% 30.00% 34.00%
Europe 3.28% 8.20% 6.56% 81.97%
North America 6.67% 6.67% 33.33% 53.33%
Oceania 0% 0% 0% 100.00%
South America 0% 6.25% 56.25% 37.50%
DORSCON Scale, Disease Outbreak Response System Condition.Twenty-eight maxillofacial surgery
departments were reported to have been
closed. By continent, nine were in Asia,
seven in Europe, five in North America,
three in Oceania, and four in South Amer-
ica. Only six maxillofacial surgery depart-
ments were reported to be functioning
normally, one each in Israel (DORSCON
orange), Japan (DORSCON red), Pakistan
(DORSCON red), Singapore (DORSCON
orange), Taiwan (DORSCON yellow),
and Poland (DORSCON yellow).Please cite this article in press as: Maffia F, et
Maxillofac Surg (2020), https://doi.org/10.1
Fig. 3. Perception of safety by continent.Globally, maxillofacial surgery de-
partmental staffing was reported to have
been reduced by 55%, ranging between an
average of 28 employees before the out-
break and an average of 11 during the
emergency.
Perception of safety varied among the
continents (Fig. 3). In Asia, the ratio of
doctors who felt ‘safe’ to those who did
not was 1:1. In North America, this ratio
was almost 3 to 1, favouring ‘safe’
(Fig. 3). al. Impact of COVID-19 on maxillofacial surge
016/j.ijom.2020.04.015Over half (57.1%) of the maxillofacial
surgery centres that reported not receiv-
ing any COVID-19 management guide-
lines, did not receive personal protective
equipment (PPE) from their administra-
tion either. Furthermore, 7% of the cen-
tres despite receiving such guidelines,
received no PPE. Of the 28 respondents
who did not receive COVID-19 manage-
ment guidelines from their administra-
tion, 57.7% did not feel ‘safe’. In
contrast, only 46.1% of the respondents
who had received such guidelines felt
‘safe’.
Table 3 shows the relationship between
outpatient visits and the DORSCON
Scale.
Table 4 shows the responses regarding
the presence or absence of changes with-
in the hospital according to the DORS-
CON Scale. Changes in protocols for
dealing with both patients who would
be undergoing surgery and those already
in the hospital were made in 48.1% of
the responding maxillofacial surgery
departments. A quarter (25.5%) changed
only inpatient protocols, while 35.1%
modified only the protocol for patients
undergoing surgery. Just over three-
quarters (78.6%) of the respondents
did not know of any change in either
of these protocols, while 66.7% reported
no change in either protocol. Of the
departments that were managing patients
who were positive for COVID-19, 71.4%
tested for the virus infection. Only
24.7% that did not manage infected
patients did likewise.ry practice: a worldwide survey, Int J Oral
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Table 3. Outpatient clinic visits during the outbreak according to the DORSCON Scale.
DORSCON Scale
Did you experience outpatient clinic visits
during the outbreak?
Yes No
Green 44.4% 55.6%
Yellow 60.0% 40.0%
Orange 56.8% 43.2%
Red 75.6% 24.4%
DORSCON Scale, Disease Outbreak Response System Condition.Discussion
COVID-19 is a coronavirus belonging to
the genus Betacoronavirus, a group of cor-
onaviruses causing infections in humans
and vertebrates. This group also includes
the Middle East respiratory syndrome-re-
lated coronavirus (MERS-CoV)4.
The virus has a zoonotic origin and
became infectious for humans after a spill-
over event5. Viruses of the Betacorona-
virus genus have a particular tropism for
the respiratory system, generating both
mild and flu-like illnesses and very severe
illnesses such as fatal pneumonia6. The
incubation period of this virus ranges from
2 to 14 days, with a mean of 5 or 6 days1,7.
This characteristic results in the potential
of encountering patients who are positive
for COVID-19 but who may still be
asymptomatic, or so-called ‘carrier’
patients4,8. The most common symptoms
at onset are fever, cough, shortness of
breath, and fatigue. Other typical symp-
toms are rhinorrhoea, sneezing, haemop-
tysis, diarrhoea, and abdominal pain4,6,9.
Severe presentations include severe acute
respiratory syndrome (SARS), with pe-
ripheral ground-glass opacities in the
lungs on chest imaging9. On March 3,
2020, the World Health Organization
(WHO) reported that the mortality rate
of patients affected by COVID-19 was
approximately 3.4%10.
The nasopharynx and nose are de-
scribed as the major reservoirs of the
virus11. Therefore, the predominant mode
of transmission of the COVID-19 virus isPlease cite this article in press as: Maffia F, et
Maxillofac Surg (2020), https://doi.org/10.1
Table 4. Department changes according to the 
DORSCON Scale
Did anything change
in hospitalizations?
No Yes 
Green 33.3% 66.7% 
Yellow 50.0% 50.0% 
Orange 21.6% 78.4% 
Red 23.3% 76.7% 
DORSCON Scale, Disease Outbreak Response direct spread from an infected patient’s
cough and/or sneeze, with others then
inhaling droplets and aerosol containing
the virus11. In addition to this mode of
infection, contact transmission via con-
tact with virus-contaminated surfaces and
then touching the oral, nasal, or conjunc-
tival mucous membranes can lead to in-
fection4.
Maxillofacial surgeons, dentists, and
otorhinolaryngologists, as well as others
who perform procedures in the head and
neck region, are at high risk of being
exposed to and infected by COVID-
1911,12. These specialties provide such
specific treatment options for patients that
it is almost impossible to transfer these
activities to other specialties for manage-
ment. This necessitates the management
of head and neck patients presenting for
treatment and the development of new
protocols to ensure provider, personnel,
and patient safety from the virus during
that treatment.
Efforts have been made by many inter-
national scientific societies to develop
guidelines for their respective
specialties13–15. While this paper focuses
on maxillofacial surgery, many of the
recommendations will be useful for all
head and neck specialties.
Every country has been facing the virus
at different times and with different inten-
sity of spread. China and Italy were the
first nations to experience an epidemic
outbreak. On April 12, 2020, the United
States (USA) was reported to be the most
affected nation in the world and Italy to al. Impact of COVID-19 on maxillofacial surge
016/j.ijom.2020.04.015
DORSCON Scale.
Did anything change in patient
preparation to undergo surgery?
I don’t know No Yes 
22.2% 44.4% 33.3% 
20.0% 45.0% 35.0% 
10.8% 35.1% 54.1% 
20.0% 27.8% 52.2% 
System Condition.have the highest number of deaths16. The
mortality rates reported by these countries
have been very different: Italy 12.8%,
China 4%, and the USA 3.7%. These
differences are explained by the number
of people tested, characteristics of each
healthcare system, and the demographics
of each country16.
According to the responses to this
survey, the majority of countries reacted
to the emergency by decreasing their
surgical activity with a reduction in
elective procedures. Only centres in
Israel, Japan, Pakistan, Poland,
Singapore, and Taiwan were still work-
ing at normal capacity, even though the
state of alert in those countries was high
on the DORSCON Scale. Taiwan post-
poned only elective cases for patients
with risk factors for infection. On com-
paring the date of the responses with the
respective national spread of the out-
break, these countries’ surgeons
responded before their country reached
the peak infection phase16. Singapore
and Taiwan represented unique models:
their governments adopted a different
policy in the management of the out-
break that focused on isolation of only
infected or possibly infected people.
They also are meticulously controlling
travelers17. This approach was evi-
denced by the high activity level
(>90%) reported by respondents from
those countries.
Another interesting phenomenon was
the variability within countries. While
one centre was working normally, another
in the same country was reducing their
activity. This trend was seen in responses
from countries like Brazil, India, Pakistan,
Turkey, and the USA. The reasons proba-
bly stem from the size of these countries,
the differences in regional administra-
tions, and the particular characteristics
of the virus control efforts. For example,
a centre from Brazil reported a peculiarity:
facial trauma as a result of personal ag-
gression and motor vehicle accidents had
decreased due to social distancing and
stay-at-home orders.ry practice: a worldwide survey, Int J Oral
Did anything change in already
hospitalized patients?
I don’t know No Yes
22.2% 66.7% 11.1%
20.0% 50.0% 30.0%
18.9% 43.2% 37.8%
28.9% 34.4% 36.7%
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with a DORSCON Scale red level, such as
Ecuador, Greece, Italy, Pakistan, Spain,
Switzerland, Turkey, and the USA, were
still experiencing outpatient visits. The
respondents stated that the procedure used
to screen potential outpatients was either a
questionnaire or pre-visit telephone call
requesting information on the patient’s
history of travel to or from high-risk areas
and possible contacts with virus-positive
people, measurement of body tempera-
ture, respiratory function status, evalua-
tion of insidious symptoms, and a quick
on-site swab test for COVID-197.
The literature reports that approximate-
ly four in five virus-positive patients are
asymptomatic7,18. This demonstrates the
importance of risk stratification during
outpatient visits and hospitalization.
However, all of the previously mentioned
preventive measures are not sufficient to
safeguard physician health and safety.
Iraq, Pakistan, the Philippines, and Spain
have taken further precautions in this
regard by creating patient appointment
schedules, whereby any patient at risk
is seen at the last appointment of the
day. In this way, thorough room sanita-
tion can be achieved without generating
any delay.
With the reduction in outpatient visits,
the majority of respondents reported that
all elective maxillofacial surgery had been
reduced or cancelled. In departments
where elective surgery was still being
performed, closer attention was being paid
to patient selection and screening. In the
Netherlands and Turkey, a chest computed
tomography scan was added to evaluate
possible signs of pneumonia. However,
for all emergency cases, the patient should
be treated as positive for the virus and
proper precautions taken11,12.
In Italy, some centres adopted a tele-
phone triage protocol to ask about the
presence of COVID-19 symptoms and
possible high-risk contacts. The patient
was then tested with a nasopharyngeal
swab 2 days before admission. If the
result was negative, the healthcare ad-
ministration allowed hospitalization. In
the postoperative phase, the nasopharynx
swab test was repeated. However, these
guidelines were adopted on April 1, 2020
after two Italian centres had already
closed on March 24, 2020 due to some
of the department staff testing positive for
the virus. In hindsight, this was too late in
light of the national course of the out-
break.
The use of prophylactic perioperative
hydrogen peroxide or povidone–iodine
mouthwash was reported by respondentsPlease cite this article in press as: Maffia F, et
Maxillofac Surg (2020), https://doi.org/10.1from Brazil and Egypt; their use is sup-
ported by the literature4. Respondents
from the Republic of South Korea and
Italy reported employing COVID-19 test-
ing only for patients scheduled for general
anaesthesia on intubation and extubation.
These procedures, as well as endoscopy,
airway suctioning, and tracheotomy, are
considered aerosol-generating procedures
(AGPs)11,12. The use of high-speed
devices like piezoelectric devices and
drills are also considered AGPs, due to
the amount of blood and saliva aerosol-
ized4. For this reason, all of these techni-
ques are considered high-risk procedures
and should be performed with a high level
of protection19.
Respondents from Brazil, India,
Indonesia, and Pakistan reported that pa-
tient intubation should be performed by
anaesthesiologists protected with FFP2
masks, as advised by the WHO20.
In Spain and Israel, operating surgeons
reported the use of two different kinds of
mask for protection, an FFP2 mask cov-
ered by a normal surgical mask, and a face
shield or goggles, or both. FFP2 or FFP3
masks and disposable suits were only
implemented in a minority of cases. Most
of the respondents did not report any
major enhancement in operating room
protocol. In Iraq, it was reported that
one centre was unable to provide adequate
PPE to its workers, so they had to purchase
FFP3 masks, goggles, and suits them-
selves.
Zou et al. doubted the effectiveness of
FFP2 masks and reported that during the
major outbreak in China, the reduction in
viral transmission to medical staff only
stabilized when PAPRs (powered, air pu-
rifying respirators) were used21. Singapore
and the USA have adopted the use these
respirators. Therefore, PAPRs should be
the primary protection for medical person-
nel treating positive patients and emergen-
cy patients who cannot be tested11,21.
There are limitations to the routine utili-
zation of these respirators in surgery, due
to their particular airflow settings, as well
as their cost and availability11. An Italian
centre has kept the number of personnel in
the operating room to a minimum, allow-
ing access to surgeons only a few minutes
before surgery, after the patient has al-
ready been prepared by the anaesthesiol-
ogists.
In Greece, Kenya, and Sri Lanka,
patients were discharged when it was
determined that hospitalization was no
longer necessary. Early discharge was
adopted by the majority of the respon-
dents. In Canada, patients were dis-
charged early in order to free up more al. Impact of COVID-19 on maxillofacial surge
016/j.ijom.2020.04.015beds. Taiwan adopted a proactive stance
by keeping some beds free in case of an
uncontrolled outbreak. In Israel, the num-
ber of inpatient visits was reduced to a
minimum, as well as their duration. Most
countries changed the hospital bed
arrangements to reduce contact between
inpatients. Other measures reported were
single-room set-ups and isolation rooms
for patients with risk factors. In Pakistan,
already hospitalized patients who were
free from COVID-19 symptoms, were
isolated until discharge. The Republic
of Korea and Israel moved all patients
to safer and well-sanitized inpatient
wards.
In a Spanish centre, wards and inten-
sive care units (ICU) were divided into
two different areas: COVID-19 positive
and negative. Generally, patients were
advised to maintain a safe distance of
1.5 meters. In addition, they were
instructed on soap and water hand wash-
ing and on hand hygiene using alcohol-
based liquids, and surgical masks were
provided. Also, the number of visitors
was reduced to one per patient and access
was only allowed for a visitor wearing
PPE. However, in many cases, no visitors
were allowed.
A high level of insecurity in the work-
place was reported in this regard. North
America respondents had the highest per-
ception of safety. Responses from Canada,
Mexico, and the USA were recorded be-
tween March 23, 2020 and March 28,
2020. In the USA during this time frame,
the cumulative number of cases increased
from 43,700 to 121,500. To date, April 12,
2020, the official number of cases is now
557,60016. In Oceania, most of the respon-
dents reported a perception of safety. The
Asian and European trend was equally
distributed. In Africa and South America,
most respondents felt unsafe about their
local situation.
Efforts are being made to develop an
efficient and effective telemedicine sys-
tem for dealing with patients as well as
medical education. Many countries,
such as the USA, reported visits and
follow-ups performed by video or tele-
phone, thereby reducing physical con-
tact. In Italy and Taiwan, university
hospital professors are using Google
Meet to continue lecturing to maxillo-
facial residents.
Not all countries and their respective
maxillofacial centres responded to the
questionnaire. One answer per country is
not enough to explain the situation prop-
erly. Personal interpretation of the ques-
tions and the personal biases of the
responses should also be considered.ry practice: a worldwide survey, Int J Oral
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many differences between continents and
countries in their handling of the COVID-
19outbreak. The COVID-19 crisis has had a
great impact on maxillofacial surgery prac-
tice all over the world, but not in the same
way. The lack of precise and timely devel-
opment of universal guidelines has resulted
in dangerous and unacceptable healthcare
settings in affected countries. This has in-
evitably resulted in unsafe working condi-
tions, made worse by the lack of PPE and
testing capabilities, all leading to high-risk
situations for many healthcare workers and
patients in many countries. However, it is
admirable that almost every centre did its
best to optimally face the outbreak. This
great effort from the maxillofacial and gen-
eral medicalcommunity has noprecedent in
history.
Protecting healthcare workers from
high-risk infection hazards is vital to en-
suring their safety while delivering care
and to avoid a healthcare system collapse.
Therefore, in conclusion, it seems appro-
priate to request that every healthcare
institution receives well-researched and
documented protocols for dealing with
future inevitable global pandemics. These
should be developed and vetted by both
local and coordinated international health-
care-based organizations. On the basis of
these guidelines, each specialty could then
develop specific and effective specialty-
based guidelines to ensure the safety and
wellbeing of providers and patients world-
wide.
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